Citation
Tian, Danmei, et al. "New Diketopiperazine Alkaloid and Polyketides From Marine-derived Fungus Penicillium Sp. TW58-16 With Antibacterial Activity Against Helicobacter Pylori." Fitoterapia, vol. 156, 2022, p. 105095.
Tian D, Gou X, Jia J, et al. New diketopiperazine alkaloid and polyketides from marine-derived fungus Penicillium sp. TW58-16 with antibacterial activity against Helicobacter pylori. Fitoterapia. 2022;156:105095.
Tian, D., Gou, X., Jia, J., Wei, J., Zheng, M., Ding, W., Bi, H., Wu, B., & Tang, J. (2022). New diketopiperazine alkaloid and polyketides from marine-derived fungus Penicillium sp. TW58-16 with antibacterial activity against Helicobacter pylori. Fitoterapia, 156, 105095. https://doi.org/10.1016/j.fitote.2021.105095
Tian D, et al. New Diketopiperazine Alkaloid and Polyketides From Marine-derived Fungus Penicillium Sp. TW58-16 With Antibacterial Activity Against Helicobacter Pylori. Fitoterapia. 2022;156:105095. PubMed PMID: 34896204.
TY - JOUR
T1 - New diketopiperazine alkaloid and polyketides from marine-derived fungus Penicillium sp. TW58-16 with antibacterial activity against Helicobacter pylori.
AU - Tian,Danmei,
AU - Gou,Xiaoshuang,
AU - Jia,Jia,
AU - Wei,Jihua,
AU - Zheng,Mingxin,
AU - Ding,Wenjuan,
AU - Bi,Hongkai,
AU - Wu,Bin,
AU - Tang,Jinshan,
Y1 - 2021/12/08/
PY - 2021/11/10/received
PY - 2021/11/30/revised
PY - 2021/11/30/accepted
PY - 2021/12/14/pubmed
PY - 2022/3/11/medline
PY - 2021/12/13/entrez
KW - Antibacterial activity
KW - Diketopiperazine alkaloid
KW - H. pylori
KW - Penicillium sp.
KW - Polyketide
SP - 105095
EP - 105095
JF - Fitoterapia
JO - Fitoterapia
VL - 156
N2 - Marine-derived fungi can usually produce structurally novel and biologically potent metabolites. In this study, a new diketopiperazine alkaloid (1) and two new polyketides (10 and 11), along with 8 known diketopiperazine alkaloids (2-9) were isolated from marine-derived fungus Penicillium sp. TW58-16. Their structures were fully elucidated by analyzing UV, IR, HR-ESI-MS, 1D, and 2D NMR spectroscopic data. The absolute configurations of the new compounds 1, 10 and 11 were ascertained by X-ray diffraction (Cu Kα radiation) and comparing their CD data with those reported. In addition, the antibacterial activities of these compounds against Helicobacter pylori in vitro were assessed. Results showed that compounds 3, 6, 8 and 9 displayed moderate antibacterial activity against standard strains and drug-resistant clinical isolates of H. pylori in vitro. This result demonstrates that diketopiperazine alkaloids could be lead compounds to be explored for the treatment of H. pylori infection.
SN - 1873-6971
UR - https://www.unboundmedicine.com/medline/citation/34896204/New_diketopiperazine_alkaloid_and_polyketides_from_marine_derived_fungus_Penicillium_sp__TW58_16_with_antibacterial_activity_against_Helicobacter_pylori_
DB - PRIME
DP - Unbound Medicine
ER -